IBM raises full-year outlook

Recent articles from IBM Investor relations

Date: 27 Feb 2008 Wednesday

On February 26, 2008, IBM's Board of Directors authorized $15 billion in additional funds for use in the company's stock repurchase program. Including the remaining balance at the end of February from a prior authorization

IBM announced $15 billion share repurchase authorization and raised full-year outlook

IBM has a long history of returning value to shareholders through a combination of share repurchase and dividends. Since 1995, IBM has spent over $94 billion to repurchase over 1.4 billion shares at an average price of $67 per share.

On February 26, 2008, IBM´s Board of Directors authorized $15 billion in additional funds for use in the company's stock repurchase program. Including the remaining balance at the end of February from a prior authorization, IBM currently has approximately $15.4 billion available for stock repurchase. At this time, IBM does not anticipate requesting board approval for additional funds for stock repurchases within the next 12 months.

IBM said it expects to spend up to $12 billion on stock repurchases in 2008. In January, the company said it expected 2008 full-year earnings per share of $8.20 to $8.30. IBM said the anticipated share repurchase activity could add up to $.05 to 2008 full-year earnings per share. The company now expects full-year 2008 earnings per share of at least $8.25, or year-to-year growth of 16 percent. The actual earnings per share impact will depend on the total amount spent, the timing of repurchases and market conditions.

IBM believes it is well positioned in the current environment, and that five factors help differentiate the company from other technology firms. These are: Global Reach and Scale, Proven Infrastructure Provider, Technology Leader, Capabilities that Create Value for Customers, and Financial Strength and Flexibility. For additional information on “The IBM Difference”, [check site link]

In this environment, investors are interested in indications of US and international demand. In the United States, the company sees strong customer demand for its solutions and offerings where it continues to provide the cost savings and productivity improvements that clients increasingly value. IBM services offerings such as IT optimization and green data center are examples of such solutions. In addition, the company’s recent short term signings performance reinforces these customer trends. In the fourth quarter, IBM had 16 percent short term signings growth in the US, and 78 percent growth in short term signings in the financial services sector in the US. These signings translate quickly to revenue, and give the company more confidence in its US performance in the current quarter. Mark Loughridge, IBM’s Chief Financial Officer, said “We’re at the end of February, so we still have a lot to do in the quarter, but at this point I feel better about our US business in the first quarter than I did in the fourth.”

IBM has tremendous global reach, and generates almost two-thirds of its revenue outside of the United States. In the fourth quarter of 2007 more than 50 countries grew revenue at greater than 10% in local currency, and collectively these countries represented 22 percent of IBM’s geographic revenue, and grew over 20 percent overall. Growth in these countries is being driven by demand for infrastructure build out – including banking, telecommunications, government, and retail.

With this geographic breadth, higher annuity-like revenue content, and broad mix of businesses, IBM's fundamental business model has provided sustainable profit and cash flow growth over the long term and a solid base of support for the company’s “2010 roadmap” objective of $10 to $11 of earnings per share. Strong earnings per share growth provides support for growth in IBM’s stock price, and the company believes, makes IBM stock a good value.

Related resources

Site links

PDF documents

RSS feeds

Investor relations search

Learn about IBM

Help and feedback

Investor relations subscriptions